Search | European Medicines Agency

This search looks for keywords in all of the website’s content. Search tips

Search results (330)

Plasma Master File dossier format and submission requirements

Last updated: 31 December 2009

HumanRegulatory and procedural guidanceResearch and development

Questions and answers: Orphan-designation application

Last updated: 31 December 2009

HumanRegulatory and procedural guidanceRare diseasesResearch and development

Coordination of GCP inspections

Last updated: 31 December 2009

HumanCompliance and inspectionsRegulatory and procedural guidanceResearch and development

Workshop on clinical outcome measures and endpoints for efficacy assessment in spinal muscular atrophy

European Medicines Agency, Amsterdam, the Netherlands

Start date: 13 October 2008

End date: 13 October 2008

EventHumanResearch and development

Ramelteon

Date of withdrawal: 19 September 2008

Last updated: 25 September 2008

MedicineHumanWithdrawn application

Lamictal - referral

lamotrigine

Article 30 referrals

Status: European Commission final decision

Opinion/position date: 24 April 2008

EC decision date: 23 July 2008

Last updated: 8 September 2008

ReferralHuman

EU/3/05/335 - orphan designation for late onset sepsis in premature infants of less or equal than 32 weeks of gestational age

Date of designation:

14 December 2005

Withdrawn

Last updated: 29 July 2008

OrphanHuman

Second European Medicines Agency workshop on neurodegenerative diseases: focus on dementia

European Medicines Agency, Amsterdam, the Netherlands

Start date: 12 February 2008

End date: 12 February 2008

EventHumanMedicinesResearch and development

Surfaxin

Date of withdrawal: 7 June 2006

Last updated: 8 June 2006

MedicineHumanWithdrawn application

EU/3/05/299 - orphan designation for treatment of pancreatic cancer

Date of designation:

27 July 2005

Positive

Last updated: 29 November 2005

OrphanHuman

Filter by

Search results (330)